DERMATITIS

This study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how much their skin improves over 12 months in real-world settings, not a controlled lab. The goal is to see how well the drug…

This study tests a new medicine called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 people will receive either the drug or a placebo to see if it reduces skin redness, swelling, and itching. The main goal is to measure improvement in eczem…

This study explores whether medical hypnosis can help children and teenagers (ages 8-17) with atopic dermatitis (eczema) manage itching, stress, and skin discomfort. Researchers will test if a hypnosis program is practical and acceptable for 32 participants. The goal is to gather…

This early-stage study tests a single dose of the experimental drug SHR-1894 in 40 healthy adults to check its safety and how the body processes it. Participants receive either the drug or a placebo by injection. The goal is to gather basic safety information, not to treat any di…

This study looks at how treatments for eczema (atopic dermatitis) change the types and amounts of bacteria on the skin. Researchers will compare skin samples from people with eczema and healthy volunteers over one year. The goal is to understand how treatments affect the skin's m…